Deutsche Bank AG Cuts Stake in Cabot Corporation $CBT

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Deutsche Bank AG cut its holdings in shares of Cabot Corporation (NYSE:CBT - Free Report) by 8.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,123 shares of the specialty chemicals company's stock after selling 4,036 shares during the period. Deutsche Bank AG owned approximately 0.08% of Cabot worth $3,668,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Ontario Teachers Pension Plan Board boosted its position in shares of Cabot by 180.8% during the first quarter. Ontario Teachers Pension Plan Board now owns 60,712 shares of the specialty chemicals company's stock valued at $5,048,000 after buying an additional 39,089 shares during the last quarter. New Age Alpha Advisors LLC boosted its position in shares of Cabot by 28.5% during the first quarter. New Age Alpha Advisors LLC now owns 3,480 shares of the specialty chemicals company's stock valued at $289,000 after buying an additional 771 shares during the last quarter. PNC Financial Services Group Inc. lifted its holdings in Cabot by 12.8% in the first quarter. PNC Financial Services Group Inc. now owns 4,356 shares of the specialty chemicals company's stock valued at $362,000 after acquiring an additional 494 shares during the period. LSV Asset Management lifted its holdings in Cabot by 318.0% in the first quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company's stock valued at $47,476,000 after acquiring an additional 434,434 shares during the period. Finally, Natixis Advisors LLC lifted its holdings in Cabot by 14.0% in the first quarter. Natixis Advisors LLC now owns 141,417 shares of the specialty chemicals company's stock valued at $11,757,000 after acquiring an additional 17,338 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Stock Performance

Shares of NYSE CBT traded up $3.9020 during trading on Friday, hitting $83.0020. The company had a trading volume of 366,335 shares, compared to its average volume of 433,899. The stock has a 50 day simple moving average of $76.69 and a 200 day simple moving average of $78.87. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. Cabot Corporation has a 12 month low of $70.40 and a 12 month high of $117.46. The firm has a market capitalization of $4.42 billion, a P/E ratio of 10.85 and a beta of 0.87.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.80 by $0.10. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The firm had revenue of $923.00 million for the quarter, compared to the consensus estimate of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. As a group, analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 11th. Stockholders of record on Friday, August 29th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.2%. Cabot's dividend payout ratio (DPR) is currently 23.53%.

Insider Activity

In related news, CEO Sean D. Keohane sold 114,436 shares of the stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the completion of the sale, the chief executive officer owned 361,518 shares in the company, valued at approximately $28,661,147.04. This trade represents a 24.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 3.03% of the company's stock.

Analyst Ratings Changes

CBT has been the topic of a number of recent research reports. Wall Street Zen downgraded Cabot from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. UBS Group set a $82.00 target price on Cabot and gave the company a "neutral" rating in a report on Tuesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $92.33.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.